Cargando…
Convalescent Plasma in a Patient with Protracted COVID-19 and Secondary Hypogammaglobulinemia Due to Chronic Lymphocytic Leukemia: Buying Time to Develop Immunity?
It is not exactly clear yet which type of immune response prevails to accomplish viral clearance in coronavirus disease 2019 (COVID-19). Studying a patient with chronic lymphocytic leukemia and hypogammaglobulinemia who suffered from COVID-19 provided insight in the immunological responses after tre...
Autores principales: | Hanssen, Jaap L. J., Stienstra, Johan, Boers, Stefan A., Pothast, Cilia R., Zaaijer, Hans L., Tjon, Jennifer M., Heemskerk, Mirjam H. M., Feltkamp, Mariet C. W., Arend, Sandra M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544405/ https://www.ncbi.nlm.nih.gov/pubmed/34698153 http://dx.doi.org/10.3390/idr13040077 |
Ejemplares similares
-
Seroprevalence of fourteen human polyomaviruses determined in blood donors
por: Kamminga, Sergio, et al.
Publicado: (2018) -
Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients
por: Singh, Namrata, et al.
Publicado: (2020) -
Prevalence of DNA of fourteen human polyomaviruses determined in blood donors
por: Kamminga, Sergio, et al.
Publicado: (2019) -
Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
por: Hueso, Thomas, et al.
Publicado: (2020) -
Hypogammaglobulinemia with Facial Edema
por: Knight, Adina Kay, et al.
Publicado: (2006)